Rhodium(III)-Based Inhibitor of the JMJD3-H3K27me3 Interaction and Modulator of the Inflammatory Response.

We describe in this study a rhodium(III) complex 1 as a new JMJD3 inhibitor and proinflammatory mediator. Complex 1 selectively inhibited the demethylation of H3K27me3 over other similar substrates, indicating its selectivity for JMJD3 over other histone demethylases, including JMJD2D and KDM5A. In terms of mechanism, complex 1 inhibited the JMJD3-H3K27me3 interaction in mouse macrophage cells and down-regulated the expression of TNF-α. To our knowledge, complex 1 is the first metal-based inhibitor of JMJD3 activity and only the second class of JMJD3 inhibitor reported overall.

[1]  C. Leung,et al.  Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy. , 2018, Angewandte Chemie.

[2]  Jian Jin,et al.  Inhibitors of Protein Methyltransferases and Demethylases , 2017, Chemical reviews.

[3]  G. Gasser,et al.  Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy. , 2017, Accounts of chemical research.

[4]  P. Sadler,et al.  Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells , 2017, Angewandte Chemie.

[5]  M. Ko,et al.  Transient ectopic expression of the histone demethylase JMJD3 accelerates the differentiation of human pluripotent stem cells , 2016, Development.

[6]  T. Kapellos,et al.  Epigenetic Control of Macrophage Polarisation and Soluble Mediator Gene Expression during Inflammation , 2016, Mediators of inflammation.

[7]  T. Haneji,et al.  Histone demethylase Jmjd3 regulates osteoblast apoptosis through targeting anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bim. , 2016, Biochimica et biophysica acta.

[8]  Min Huang,et al.  Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors. , 2016, Bioorganic & medicinal chemistry letters.

[9]  Wei Liu,et al.  Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity. , 2015, Angewandte Chemie.

[10]  C. Leung,et al.  An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator. , 2015, Journal of medicinal chemistry.

[11]  Kristian Helin,et al.  Inhibition of demethylases by GSK-J1/J4 , 2014, Nature.

[12]  A. Salminen,et al.  Histone demethylase Jumonji D3 (JMJD3/KDM6B) at the nexus of epigenetic regulation of inflammation and the aging process , 2014, Journal of Molecular Medicine.

[13]  E. Novellino,et al.  Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities. , 2014, Journal of medicinal chemistry.

[14]  L. Ji,et al.  The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes. , 2013, Metallomics : integrated biometal science.

[15]  Christopher J. Schofield,et al.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response , 2012, Nature.

[16]  P. Sadler,et al.  Metal complexes as DNA intercalators. , 2011, Accounts of chemical research.

[17]  Giuseppe Testa,et al.  Jmjd3 contributes to the control of gene expression in LPS-activated macrophages , 2009, The EMBO journal.

[18]  M. C. Feiters,et al.  AFM and electron microscopy study of the unusual aggregation behavior of metallosurfactants based on iron(II) complexes with bipyridine ligands. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[19]  R. Pascal,et al.  Accelerated luminophore discovery through combinatorial synthesis. , 2004, Journal of the American Chemical Society.